SOL Global Investments Corp, formerly Scythian Biosciences Corp, is a Canada-based investment company. The Company is focused on offering strategic investments and partnerships across cultivation, distribution and retail complement the Company’s research and development (R&D) program with the University of Miami. It is engaged in the process of developing drug therapies. The Company conducts a project regarding development of a cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. The Company also provides a research in area of treatment of gastro-inflammatory disease.